Document is current
Any future updates will be listed below
-
Authors
de Gooyer, Peter G. M.
Verschoor, Yara L. https://orcid.org/0009-0005-7217-1460
van den Dungen, Lauren D. W.
Balduzzi, Sara https://orcid.org/0000-0003-1205-1895
Marsman, Hendrik A.
Geukes Foppen, Marnix H.
Grootscholten, Cecile
Dokter, Simone
den Hartog, Anne G.
Verbeek, Wieke H. M.
Woensdregt, Karlijn
van den Broek, Joris J.
Oosterling, Steven J.
Schumacher, Ton N. https://orcid.org/0000-0003-0517-8804
Kuhlmann, Koert F. D.
Beets-Tan, Regina G. H.
Haanen, John B. A. G. https://orcid.org/0000-0001-5884-7704
van Leerdam, Monique E. https://orcid.org/0000-0002-5719-3208
van den Berg, Jose G.
Chalabi, Myriam https://orcid.org/0000-0002-8607-6174
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 29 July 2024
Accepted: 14 August 2024
First Online: 15 September 2024
Competing interests
: J.B.A.G.H. is an advisor to Achilles Therapeutics, AstraZeneca, BioNTech, Bristol Myers Squibb, Curevac, Gadeta, Imcyse, Immunocore, Iovance Therapeutics, Ipsen, Merck Serono, Merck Sharp & Dohme, Molecular Partners, Neogene Therapeutics, Novartis, Pfizer, PokeAcel, Roche, Sanofi, Sastra Cell Therapy, Third Rock Ventures and T-Knife and has received research grants unrelated to this study from Amgen, Asher Bio, BioNTech US, Bristol Myers Squibb, Merck Sharp & Dohme, Novartis and Sastra Cell Therapy. J.B.A.G.H. owns stock in Neogene Therapeutics. All grants were paid to the institutions. T.N.S. is a venture partner at Third Rock Ventures. T.N.S. is founder of, advisor to and stockholder in Asher Bio, Cell Control and Neogene Therapeutics. T.N.S. is advisor to and stockholder in Allogene Therapeutics, Merus and Scenic Biotech. M.C. is advisor to Bristol Myers Squibb, Kineta, Merck Sharp & Dohme, NOUSCOM and Roche/Genentech and has received research grants unrelated to this study from Agenus, Merck Sharp & Dohme and Roche/Genentech. All grants were paid to the institutions. The other authors declare no competing interests.
